In this prospective observational cohort study carried out by Charité – Universitätsmedizin Berlin, symptom severity and various biomarkers were evaluated in 106 patients with Post-COVID-19 syndrome (PCS) with moderate to severe fatigue and exertion intolerance at three-time points after infection.
The main aim of this study published by eClinicalMedicine was to determine differences in the disease course between the two patient groups (i.e., PCS vs PCS-ME/CFS) and identify correlating biomarkers.
The full article can be found below:
